NovaBay Pharmaceuticals Inc (NBY)
0.681
-0.04
(-5.39%)
USD |
NYAM |
Nov 22, 16:00
0.673
-0.01
(-1.17%)
After-Hours: 20:00
NovaBay Pharmaceuticals Free Cash Flow: -4.812M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -4.812M |
| June 30, 2024 | -3.396M |
| March 31, 2024 | -4.524M |
| December 31, 2023 | -4.15M |
| September 30, 2023 | -4.764M |
| June 30, 2023 | -5.886M |
| March 31, 2023 | -5.885M |
| December 31, 2022 | -6.766M |
| September 30, 2022 | -9.883M |
| June 30, 2022 | -9.599M |
| March 31, 2022 | -9.881M |
| December 31, 2021 | -9.244M |
| September 30, 2021 | -6.384M |
| June 30, 2021 | -6.274M |
| March 31, 2021 | -5.326M |
| December 31, 2020 | -4.747M |
| September 30, 2020 | -4.71M |
| June 30, 2020 | -4.835M |
| March 31, 2020 | -5.578M |
| December 31, 2019 | -7.948M |
| September 30, 2019 | -8.543M |
| June 30, 2019 | -8.669M |
| March 31, 2019 | -8.381M |
| December 31, 2018 | -5.612M |
| September 30, 2018 | -6.53M |
| Date | Value |
|---|---|
| June 30, 2018 | -4.696M |
| March 31, 2018 | -4.915M |
| December 31, 2017 | -6.514M |
| September 30, 2017 | -3.874M |
| June 30, 2017 | -7.971M |
| March 31, 2017 | -8.937M |
| December 31, 2016 | -11.82M |
| September 30, 2016 | -16.08M |
| June 30, 2016 | -16.36M |
| March 31, 2016 | -19.11M |
| December 31, 2015 | -18.68M |
| September 30, 2015 | -18.26M |
| June 30, 2015 | -16.89M |
| March 31, 2015 | -15.22M |
| December 31, 2014 | -15.12M |
| September 30, 2014 | -15.76M |
| June 30, 2014 | -15.38M |
| March 31, 2014 | -13.84M |
| December 31, 2013 | -13.11M |
| September 30, 2013 | -11.52M |
| June 30, 2013 | -8.901M |
| March 31, 2013 | -7.641M |
| December 31, 2012 | -6.676M |
| September 30, 2012 | -4.077M |
| June 30, 2012 | -3.504M |
Free Cash Flow Range, Past 5 Years
-9.883M
Minimum
Sep 2022
-3.396M
Maximum
Jun 2024
-6.230M
Average
-5.732M
Median
Free Cash Flow Benchmarks
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
| Oragenics Inc | -7.682M |
| Nanoviricides Inc | -7.934M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.061M |
| Cash from Investing (Quarterly) | -0.002M |
| Cash from Financing (Quarterly) | 2.089M |
| Free Cash Flow Per Share (Quarterly) | -0.5561 |
| Free Cash Flow to Equity (Quarterly) | -1.418M |
| Free Cash Flow Yield | -479.8% |